Walgreens Boots Alliance, Inc. (WBA) Declares Quarterly Dividend of $0.40
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) declared a quarterly dividend on Thursday, July 13th, Wall Street Journal reports. Investors of record on Friday, August 18th will be given a dividend of 0.40 per share by the pharmacy operator on Tuesday, September 12th. This represents a $1.60 dividend on an annualized basis and a yield of 2.06%. The ex-dividend date is Wednesday, August 16th. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38.
Walgreens Boots Alliance (WBA) traded up 0.651% during trading on Thursday, reaching $78.025. 4,612,187 shares of the company were exchanged. Walgreens Boots Alliance has a one year low of $75.18 and a one year high of $88.00. The firm’s 50-day moving average is $80.89 and its 200 day moving average is $83.32. The company has a market capitalization of $83.49 billion, a P/E ratio of 19.703 and a beta of 1.26.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share for the quarter, beating analysts’ consensus estimates of $1.30 by $0.03. The business had revenue of $30.12 billion for the quarter, compared to the consensus estimate of $29.72 billion. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. Walgreens Boots Alliance’s quarterly revenue was up 2.1% on a year-over-year basis. During the same period last year, the firm posted $1.18 earnings per share. On average, analysts anticipate that Walgreens Boots Alliance will post $5.01 EPS for the current fiscal year.
Several research analysts have commented on the stock. Needham & Company LLC raised shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $94.00 price target on the stock in a research note on Friday, June 30th. Zacks Investment Research raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Thursday, March 23rd. Deutsche Bank AG reissued a “buy” rating and set a $92.00 price target on shares of Walgreens Boots Alliance in a research note on Wednesday, March 22nd. Robert W. Baird reissued an “outperform” rating and set a $96.00 price target on shares of Walgreens Boots Alliance in a research note on Monday, March 27th. Finally, Jefferies Group LLC reissued a “buy” rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a research note on Thursday, April 6th. Three analysts have rated the stock with a sell rating, three have assigned a hold rating and thirteen have given a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $90.47.
In related news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction dated Wednesday, May 3rd. The shares were sold at an average price of $85.89, for a total value of $234,995.04. Following the transaction, the director now owns 21,887 shares in the company, valued at approximately $1,879,874.43. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 13.50% of the company’s stock.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.